Clinical trial

US Inhaled Insulin Dose Titration Study

NCT00246623

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-11-01

PhasePHASE3

Study timeline

Study start (unknown)2005-11-01Date precision: month

Registry last updated2008-02-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Interventions

Exubera (inhaled insulin)DRUG

8-point glucose diary (to assess pre- and post prandial glucoses)PROCEDURE

Meal Tolerance TestPROCEDURE

24-hour continuous glucose monitoring (at select sites)PROCEDURE

Pulmonary Function TestingPROCEDURE

Hypoglycemic Event MonitoringPROCEDURE

Laboratory AssessmentsPROCEDURE

Nutritional Counseling and Diabetes EducationBEHAVIORAL

Sponsors & collaborators

Pfizerlead sponsor

Sanoficollaborator

Mapped research locations

BostonMassachusetts, United States1 Los AngelesCalifornia, United States1 DallasTexas, United States1 AtlantaGeorgia, United States1 San AntonioTexas, United States1 BirminghamAlabama, United States1 AlbanyNew York, United States1 SyracuseNew York, United States1 Baton RougeLouisiana, United States1 HollywoodFlorida, United States1 El PasoTexas, United States1 BoiseIdaho, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00246623 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.